OrthoPediatrics Joins Alliance for Pediatric Device Innovation
12 Octobre 2023 - 2:05PM
OrthoPediatrics Corp. (“OrthoPediatrics” or the
“Company”) (Nasdaq: KIDS) a company focused exclusively on
advancing the field of pediatric orthopedics, has announced a
strategic partnership with Children’s National Hospital in
Washington, DC under the “Alliance for Pediatric Device Innovation”
(APDI), to advice the development and commercialization of medical
devices designed for children.
Along with Children’s National, APDI consortium
members include Johns Hopkins University, CIMIT at Mass General
Brigham, Tufts Medical Center and Medstar Health Research
Institute. The Company will serve as APDI’s strategic advisor and
role model for device innovators whose primary focus is children.
Children’s National and APDI are also partnering with MedTech
Color, a collaborative community that is part of FDA’s Center for
Devices and Radiological Health, to host competitions and
accelerator wraparound services exclusively for medical technology
entrepreneurs of African American and Hispanic backgrounds.
The Food and Drug Administration (FDA) has
awarded a nearly $7.5 million grant to the APDI. The nonprofit
group, which is one of five in the FDA’s Pediatric Device Consortia
(PDC) program, will utilize the five-year grant to provide a
platform of services, expertise and funding that supports pediatric
innovators in bringing medical devices to the market that
specifically address the needs of children. New in this cycle, APDI
will provide expertise on evidence generation, including the use of
real-world evidence (RWE), for pediatric device development.
Pediatric medical device development continues
to lag significantly behind that of adults because of a variety of
challenges, including complexities in designing devices for growing
children, small market size and lack of financial incentives. To
address this health inequity, the FDA provides support through the
consortia grant program to advance the development of medical
devices for children.
APDI is led by program director and principal
investigator Kolaleh Eskandanian, Ph.D., M.B.A., vice president and
chief innovation officer at Children’s National, and principal
investigator Julia Finkel, M.D., pediatric anesthesiologist and
director of Pain Medicine Research and Development in the Sheikh
Zayed Institute for Pediatric Surgical Innovation. “Children are
our future, and they deserve to benefit from the best advancements
that medical technology can offer,” Eskandanian says. “Children’s
National looks forward to continuing our work as a champion for
medical device innovation for children. Working with our
distinguished consortium partners, we will build upon our
collective strengths to bring more pediatric devices to patient
care while minimizing the barriers to device innovation.”
OrthoPediatrics President and CEO, David Bailey
commented “We are excited to join the APDI with our partners at
Children’s National Hospital and John’s Hopkins University. This
coalition of thought-leaders will help us advance all aspects of
pediatric medicine for years to come. Since the inception of the
company, OP has been focused exclusively on improving healthcare
for KIDS, and this will further enable us to reach more patients
with devices and treatment options that are designed specifically
for them.”
About OrthoPediatrics
Corp.Founded in 2006, OrthoPediatrics is an
orthopedic company focused exclusively on advancing the field of
pediatric orthopedics. As such it has developed the most
comprehensive product offering to the pediatric orthopedic market
to improve the lives of children with orthopedic
conditions. OrthoPediatrics currently markets 52 surgical
systems that serve three of the largest categories within the
pediatric orthopedic market. This product offering spans trauma and
deformity, scoliosis, and sports medicine/other procedures.
OrthoPediatrics’ global sales organization is focused exclusively
on pediatric orthopedics and distributes its products in the
United States and over 70 countries outside the United
States. For more information, please
visit www.orthopediatrics.com.
About Children’s National
HospitalChildren’s National Hospital, based in Washington,
D.C., was established in 1870 to help every child grow up stronger.
Today, it is the No. 5 children’s hospital in the nation and ranked
in all specialties evaluated by U.S. News & World Report.
Children’s National is transforming pediatric medicine for all
children. The Children’s National Research & Innovation Campus
opened in 2021, a first-of-its-kind pediatric hub dedicated to
developing new and better ways to care for kids. Children’s
National has been designated three times in a row as a Magnet®
hospital, demonstrating the highest standards of nursing and
patient care delivery. This pediatric academic health system offers
expert care through a convenient, community-based primary care
network and specialty care locations in the D.C. metropolitan area,
including Maryland and Virginia. Children’s National is home to the
Children’s National Research Institute and Sheikh Zayed Institute
for Pediatric Surgical Innovation. It is recognized for its
expertise and innovation in pediatric care and as a strong voice
for children through advocacy at the local, regional and national
levels. As a non-profit, Children’s National relies on generous
donors to help ensure that every child receives the care they
need.
Investor ContactPhilip Trip
Taylor Gilmartin Groupphilip@gilmartinir.com415-937-5406
OrthoPediatrics (NASDAQ:KIDS)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
OrthoPediatrics (NASDAQ:KIDS)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024